• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 在卵巢上皮性癌转移中的作用。

The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.

机构信息

Department of Biology, York University, Toronto, ON M3J 1P3, Canada.

Centre for Research in Biomolecular Interactions, York University, Toronto, ON M3J 1P3, Canada.

出版信息

Int J Mol Sci. 2020 Sep 25;21(19):7093. doi: 10.3390/ijms21197093.

DOI:10.3390/ijms21197093
PMID:32993038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7583982/
Abstract

Epithelial ovarian cancer (EOC) is the deadliest gynecological cancer, and the major cause of death is mainly attributed to metastasis. MicroRNAs (miRNAs) are a group of small non-coding RNAs that exert important regulatory functions in many biological processes through their effects on regulating gene expression. In most cases, miRNAs interact with the 3' UTRs of target mRNAs to induce their degradation and suppress their translation. Aberrant expression of miRNAs has been detected in EOC tumors and/or the biological fluids of EOC patients. Such dysregulation occurs as the result of alterations in DNA copy numbers, epigenetic regulation, and miRNA biogenesis. Many studies have demonstrated that miRNAs can promote or suppress events related to EOC metastasis, such as cell migration, invasion, epithelial-to-mesenchymal transition, and interaction with the tumor microenvironment. In this review, we provide a brief overview of miRNA biogenesis and highlight some key events and regulations related to EOC metastasis. We summarize current knowledge on how miRNAs are dysregulated, focusing on those that have been reported to regulate metastasis. Furthermore, we discuss the role of miRNAs in promoting and inhibiting EOC metastasis. Finally, we point out some limitations of current findings and suggest future research directions in the field.

摘要

上皮性卵巢癌(EOC)是最致命的妇科癌症,主要死亡原因主要归因于转移。微小 RNA(miRNA)是一组小的非编码 RNA,通过调节基因表达来发挥重要的调节功能,参与许多生物学过程。在大多数情况下,miRNA 通过与靶 mRNA 的 3'UTR 相互作用来诱导其降解并抑制其翻译。已经在 EOC 肿瘤和/或 EOC 患者的生物体液中检测到 miRNA 的异常表达。这种失调是由于 DNA 拷贝数、表观遗传调控和 miRNA 生物发生的改变而发生的。许多研究表明,miRNA 可以促进或抑制与 EOC 转移相关的事件,如细胞迁移、侵袭、上皮-间充质转化以及与肿瘤微环境的相互作用。在这篇综述中,我们简要概述了 miRNA 的生物发生,并强调了与 EOC 转移相关的一些关键事件和调控。我们总结了目前关于 miRNA 失调的知识,重点介绍了那些被报道调节转移的 miRNA。此外,我们还讨论了 miRNA 在促进和抑制 EOC 转移中的作用。最后,我们指出了目前研究结果的一些局限性,并提出了该领域未来的研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8668/7583982/b62687ca6a8c/ijms-21-07093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8668/7583982/b62687ca6a8c/ijms-21-07093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8668/7583982/b62687ca6a8c/ijms-21-07093-g001.jpg

相似文献

1
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.微小 RNA 在卵巢上皮性癌转移中的作用。
Int J Mol Sci. 2020 Sep 25;21(19):7093. doi: 10.3390/ijms21197093.
2
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.卵巢癌中异常甲基化调控的新型 miRNA 基因参与转移。
Gene. 2018 Jul 1;662:28-36. doi: 10.1016/j.gene.2018.04.005. Epub 2018 Apr 6.
3
MicroRNA-505-3p mediates cell motility of epithelial ovarian cancer via suppressing PEAK1 expression.微小 RNA-505-3p 通过抑制 PEAK1 表达来介导上皮性卵巢癌细胞的运动能力。
J Biochem Mol Toxicol. 2024 Jul;38(7):e23767. doi: 10.1002/jbt.23767.
4
Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.长链非编码 RNA TC0101441 通过下调 KiSS1 诱导上皮性卵巢癌转移中的上皮-间充质转化。
Int J Cancer. 2020 May 1;146(9):2588-2598. doi: 10.1002/ijc.32692. Epub 2019 Dec 5.
5
S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.S100A7 通过 MAPK 信号调节卵巢癌细胞转移和化疗耐药性,并且受 miR-330-5p 靶向调控。
DNA Cell Biol. 2018 May;37(5):491-500. doi: 10.1089/dna.2017.3953. Epub 2018 Feb 27.
6
Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer.脂肪细胞衍生的外泌体促进卵巢癌细胞侵袭并挑战紫杉醇疗效。
Cell Commun Signal. 2024 Sep 16;22(1):443. doi: 10.1186/s12964-024-01806-4.
7
DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.DPY30 对于增强上皮性卵巢癌细胞的增殖、迁移和上皮-间充质转化是必需的。
Int J Mol Med. 2018 Dec;42(6):3065-3072. doi: 10.3892/ijmm.2018.3869. Epub 2018 Sep 11.
8
BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.Bach1 通过 HMGA2 介导的上皮-间充质转化促进人卵巢癌细胞转移。
Cancer Lett. 2019 Mar 31;445:45-56. doi: 10.1016/j.canlet.2019.01.003. Epub 2019 Jan 14.
9
Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype.缺氧上皮性卵巢癌细胞来源的外泌体将 microRNAs 递送至巨噬细胞并引发促进肿瘤的表型。
Cancer Lett. 2018 Oct 28;435:80-91. doi: 10.1016/j.canlet.2018.08.001. Epub 2018 Aug 8.
10
HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.HOXD-AS1 通过调节 miR-186-5p 和 PIK3R3 促进卵巢癌细胞的上皮间质转化。
J Exp Clin Cancer Res. 2019 Mar 1;38(1):110. doi: 10.1186/s13046-019-1103-5.

引用本文的文献

1
Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance.卵巢癌化疗耐药中的信号网络与微小RNA相互作用
J Ovarian Res. 2025 Aug 14;18(1):185. doi: 10.1186/s13048-025-01770-8.
2
Treatment of ovarian cancer: From the past to the new era (Review).卵巢癌的治疗:从过去到新时代(综述)
Oncol Lett. 2025 Jun 3;30(2):384. doi: 10.3892/ol.2025.15130. eCollection 2025 Aug.
3
Integrated miRNA Profiling of Extracellular Vesicles from Uterine Aspirates, Malignant Ascites and Primary-Cultured Ascites Cells for Ovarian Cancer Screening.

本文引用的文献

1
Wise Management of Ovarian Cancer: On the Cutting Edge.卵巢癌的明智管理:处于前沿领域
J Pers Med. 2020 May 21;10(2):41. doi: 10.3390/jpm10020041.
2
Overexpression of miR-32 inhibits the proliferation and metastasis of ovarian cancer cells by targeting BTLA.miR-32的过表达通过靶向BTLA抑制卵巢癌细胞的增殖和转移。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4671-4678. doi: 10.26355/eurrev_202005_21154.
3
MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
用于卵巢癌筛查的子宫抽吸物、恶性腹水及原代培养腹水细胞来源细胞外囊泡的综合miRNA分析
Pharmaceutics. 2024 Jul 5;16(7):902. doi: 10.3390/pharmaceutics16070902.
4
MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.人类样本和细胞系中的 microRNA 表达谱揭示了与高级别浆液性卵巢癌顺铂耐药相关的 9 个 miRNA。
Int J Mol Sci. 2024 Mar 28;25(7):3793. doi: 10.3390/ijms25073793.
5
New long noncoding RNA biomarkers and ceRNA networks on miR-616-3p in colorectal cancer: Bioinformatics-based study.基于生物信息学的研究:结直肠癌中miR-616-3p相关新的长链非编码RNA生物标志物及ceRNA网络
J Res Med Sci. 2024 Feb 23;29:10. doi: 10.4103/jrms.jrms_786_22. eCollection 2024.
6
Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer Cells.水蛭素介导的卵巢癌细胞增殖抑制机制。
Mol Biotechnol. 2024 May;66(5):1062-1070. doi: 10.1007/s12033-023-01003-7. Epub 2024 Jan 7.
7
The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis.长链非编码 RNA NEAT1 通过靶向 miR-214-3p 并调节血管生成促进人卵巢癌的进展。
J Ovarian Res. 2023 Nov 20;16(1):219. doi: 10.1186/s13048-023-01309-9.
8
MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity.微小RNA可通过失调整合素活性影响卵巢癌进展。
Cancers (Basel). 2023 Sep 8;15(18):4449. doi: 10.3390/cancers15184449.
9
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer.RO-3306 通过抑制 CDK1 在卵巢癌细胞和卵巢癌转基因小鼠模型中表现出抗肿瘤作用。
Int J Mol Sci. 2023 Aug 3;24(15):12375. doi: 10.3390/ijms241512375.
10
miR-486 Responds to Apoptosis and Autophagy by Repressing SRSF3 Expression in Ovarian Granulosa Cells of Dairy Goats.miR-486 通过抑制奶牛卵巢颗粒细胞中 SRSF3 的表达来响应细胞凋亡和自噬。
Int J Mol Sci. 2023 May 15;24(10):8751. doi: 10.3390/ijms24108751.
MicroRNA-489 通过调控 PI3K/Akt 信号通路和上皮间质转化抑制 XIAP 抑制卵巢癌细胞的生物学进展。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4113-4122. doi: 10.26355/eurrev_202004_20990.
4
MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4.微小 RNA-145-5p 通过靶向 SMAD4 调节上皮性卵巢癌细胞的增殖。
J Ovarian Res. 2020 May 4;13(1):54. doi: 10.1186/s13048-020-00656-1.
5
Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation.来自转移微环境的信号通过下调miR-4454调控早期和晚期卵巢癌转移。
Mol Cancer Res. 2020 Aug;18(8):1202-1217. doi: 10.1158/1541-7786.MCR-19-1162. Epub 2020 Apr 29.
6
Inhibition of miR-141 and miR-200a Increase and Expression, Enhance Migration and Invasion in Metastatic Serous Ovarian Cancer.抑制 miR-141 和 miR-200a 增加和表达,增强转移性浆液性卵巢癌的迁移和侵袭。
Int J Environ Res Public Health. 2020 Apr 17;17(8):2766. doi: 10.3390/ijerph17082766.
7
LncRNA EMX2OS Induces Proliferation, Invasion and Sphere Formation of Ovarian Cancer Cells via Regulating the miR-654-3p/AKT3/PD-L1 Axis.长链非编码RNA EMX2OS通过调控miR-654-3p/AKT3/PD-L1轴诱导卵巢癌细胞增殖、侵袭及成球
Cancer Manag Res. 2020 Mar 24;12:2141-2154. doi: 10.2147/CMAR.S229013. eCollection 2020.
8
MiR-202-5p suppressed cell proliferation, migration and invasion in ovarian cancer via regulating HOXB2.miR-202-5p 通过调控 HOXB2 抑制卵巢癌细胞增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2256-2263. doi: 10.26355/eurrev_202003_20491.
9
MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.miR-29c-3p,LINC01296 的一个靶 miRNA,加速肿瘤恶性进展:LINC01296/miR-29c-3p 轴在卵巢癌中的治疗潜力。
J Ovarian Res. 2020 Mar 19;13(1):31. doi: 10.1186/s13048-020-00631-w.
10
Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.长非编码 RNA RHPN1-AS1 通过作为 ceRNA 对抗 miR-596 并上调 LETM1 促进卵巢癌的发生和转移。
Aging (Albany NY). 2020 Mar 12;12(5):4558-4572. doi: 10.18632/aging.102911.